| 1 | 2095551-89-4 | SAS-0132 | SAS-0132 | C24H29N3O2
| | |
| 2 | 1435192-04-3 | NCGC00247743 | NCGC00247743 | C24H29N3O2
| | |
| 3 | 2099128-83-1 | 比拉斯汀杂质8 | Bilastine Impurity 19 | C24H29N3O2
| | |
| 4 | 658084-64-1 | FK866 (APO866, Daporinad) | FK866 (APO866, Daporinad) | C24H29N3O2
| 代谢;小分子抑制剂;细胞生物学试剂;小分子抑制剂，天然产物;试剂盒-细胞分析试剂盒 | |
| 5 | | 4,6-bis[4-(tert-butyl)phenoxy]-2-pyrimidinamine | 4,6-bis[4-(tert-butyl)phenoxy]-2-pyrimidinamine | C24H29N3O2
| | |
| 6 | 485394-20-5 | 双[2-((4S)-4,5-二氢-4-异丙基恶唑-2-基)苯基]胺 | Bis[2-((4S)-4,5-dihydro-4-isopropyloxazol-2-yl)phenyl]amine | C24H29N3O2
| | |
| 7 | 1158781-22-6 | N-[4-(4-acetyl-1-piperazinyl)phenyl]-1-phenylcyclopentanecarboxamide | N-[4-(4-acetyl-1-piperazinyl)phenyl]-1-phenylcyclopentanecarboxamide | C24H29N3O2
| | |
| 8 | 1198425-96-5 | (E)-N-[4-(1-benzoylpiperidin-4-yl)butyl]-3-pyridin-3-ylprop-2-enamide | (E)-N-[4-(1-benzoylpiperidin-4-yl)butyl]-3-pyridin-3-ylprop-2-enamide | C24H29N3O2
| | |
| 9 | | N1-(2-{5-[4-(tert-butyl)phenyl]-1,3,4-oxadiazol-2-yl}phenyl)hexanamide | N1-(2-{5-[4-(tert-butyl)phenyl]-1,3,4-oxadiazol-2-yl}phenyl)hexanamide | C24H29N3O2
| | |
| 10 | 898532-85-9 | 2-BenzofurancarboxaMide, N-[4-[4-(3-Methylphenyl)-1-piperazinyl]butyl]- | 2-BenzofurancarboxaMide, N-[4-[4-(3-Methylphenyl)-1-piperazinyl]butyl]- | C24H29N3O2
| | |
| 11 | 1044764-12-6 | 4-[[4-(1H-吲哚-4-基)-1-哌嗪基]甲基]苯甲酸叔丁酯 | 4-[[4-(1H-Indol-4-yl)-1-piperazinyl]methyl]benzoic acid tert-butyl ester | C24H29N3O2
| | |
| 12 | | 1-[2-(4-Methyl-1-piperazinyl)ethyl]-3-(4-methoxybenzoyl)-2-methyl-1H-indole | 1-[2-(4-Methyl-1-piperazinyl)ethyl]-3-(4-methoxybenzoyl)-2-methyl-1H-indole | C24H29N3O2
| | |
| 13 | 342593-28-6 | 3-[(3,5-ditert-butyl-4-hydroxybenzylidene)amino]-2-methyl-4(3H)-quinazolinone | 3-[(3,5-ditert-butyl-4-hydroxybenzylidene)amino]-2-methyl-4(3H)-quinazolinone | C24H29N3O2
| | |
| 14 | | (3R,4S)-3-(4-Aminophenyl)-4-phenyl-1-(2-piperidinopropyl)pyrrolidine-2,5-dione | (3R,4S)-3-(4-Aminophenyl)-4-phenyl-1-(2-piperidinopropyl)pyrrolidine-2,5-dione | C24H29N3O2
| | |
| 15 | | 4-(1-BENZYL-1H-BENZOIMIDAZOL-2-YL)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER | 4-(1-BENZYL-1H-BENZOIMIDAZOL-2-YL)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER | C24H29N3O2
| | |
| 16 | | CIS-6-BENZYLOXYMETHYL-3,4-DIMETHYL-3-CYCLOHEXENECARBALDEHYDE4-PHENYLSEMICARBAZONE | CIS-6-BENZYLOXYMETHYL-3,4-DIMETHYL-3-CYCLOHEXENECARBALDEHYDE4-PHENYLSEMICARBAZONE | C24H29N3O2
| | |
| 17 | 86684-57-3 | 4-Morpholinepropanamine, alpha-methyl-N-(3-phenyl-5-isoxazolyl)-N-(phe nylmethyl)- | 4-Morpholinepropanamine, alpha-methyl-N-(3-phenyl-5-isoxazolyl)-N-(phe nylmethyl)- | C24H29N3O2
| | |
| 18 | | 4-(BENZYL-METHYL-AMINO)-5-(4-TERT-BUTYL-BENZYL)-6-HYDROXY-1-METHYL-1H-PYRIMIDIN-2-ONE | 4-(BENZYL-METHYL-AMINO)-5-(4-TERT-BUTYL-BENZYL)-6-HYDROXY-1-METHYL-1H-PYRIMIDIN-2-ONE | C24H29N3O2
| | |
| 19 | 919069-26-4 | 2-[4-(1H-benzimidazol-2-yl)-1-piperidinyl]-2-oxoethyl 2-isopropyl-5-methylphenyl ether | 2-[4-(1H-benzimidazol-2-yl)-1-piperidinyl]-2-oxoethyl 2-isopropyl-5-methylphenyl ether | C24H29N3O2
| | |
| 20 | | N-[3-(Diethylamino)propyl]-2-methyl-1-oxo-4-phenyl-1,2-dihydro-3-isoquinolinecarboxamide | N-[3-(Diethylamino)propyl]-2-methyl-1-oxo-4-phenyl-1,2-dihydro-3-isoquinolinecarboxamide | C24H29N3O2
| | |
| 21 | 78945-87-6 | | 3-Isoquinolinecarboxamide, N-[3-(diethylamino)propyl]-1,2-dihydro-2-methyl-1-oxo-4-phenyl- | C24H29N3O2
| | |
| 22 | 60422-87-9 | 3-[(Z)-[2-(1,1-Dimethyl-2-propenyl)-5-(3-methyl-2-butenyl)-1H-indol-3-yl]methylene]-6-methyl-2,5-piperazinedione | 3-[(Z)-[2-(1,1-Dimethyl-2-propenyl)-5-(3-methyl-2-butenyl)-1H-indol-3-yl]methylene]-6-methyl-2,5-piperazinedione | C24H29N3O2
| | |
| 23 | 57765-86-3 | (6S,3Z)-6α-Methyl-3-[[2-(1,1-dimethyl-2-propenyl)-6-(3-methyl-2-butenyl)-1H-indol-3-yl]methylene]piperazine-2,5-dione | (6S,3Z)-6α-Methyl-3-[[2-(1,1-dimethyl-2-propenyl)-6-(3-methyl-2-butenyl)-1H-indol-3-yl]methylene]piperazine-2,5-dione | C24H29N3O2
| | |
| 24 | 957780-76-6 | | (3Z,6S)-3-[[2-(1,1-Dimethyl-2-propen-1-yl)-7-(3-methyl-2-buten-1-yl)-1H-indol-3-yl]methylene]-6-methyl-2,5-piperazinedione | C24H29N3O2
| | |